Prognostic value of PD-L1 expression on tumor cells combined with CD8+ TIL density in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy.

Kathrin GennenLukas KäsmannJulian TaugnerChukwuka EzeMonika KarinOlarn RoengvoraphojJens NeumannAmanda TufmanMichael OrthSimone ReuClaus BelkaFarkhad Manapov

Published in: Radiation oncology (London, England) (2020)

Assessment of PD-L1 expression on tumor cells in combination with CD8+ TIL density can be a predictive biomarker in patients with inoperable LA-NSCLC treated with concurrent CRT.

Keyphrases

advanced non small cell lung cancer
locally advanced
epidermal growth factor receptor
rectal cancer
squamous cell carcinoma
radiation therapy
small cell lung cancer
nk cells
newly diagnosed
tyrosine kinase
heart failure
cardiac resynchronization therapy